Nonetheless, our study demonstrates for the first time that Vin possesses anti-osteoclastogenic and anti-resorptive properties which can be exploited to our benefit for the management or treatment of osteoclast-mediated osteolytic diseases such as osteoporosis. This evidence concerns the gene LINC01191 and osteoporosis.